Treatment of Severe Dry Eye in Stevens-Johnson Syndrome with Umbilical Cord Serum Eye Drops

Purpose: To evaluate the efficacy and safety of umbilical cord serum eye drops for dry eyes in ocular Stevens-Johnson Syndrome (SJS). Patients and Methods: A pre-post test study with umbilical cord serum (UCS) eye drop for ocular SJS patient with moderate to severe dry eyes. Study was conducted at Kirana Cipto Mangunkusumo General Hospital from June 2020 to December 2020. A total of five patients (five eyes) with a diagnosis of SJS more than 6 months, dry eye symptoms, and abnormal tear stability test results were included in the study. Each patient was asked to instill UCS drop into the affected eye six times daily. Evaluation of ocular symptoms with ocular surface disease index (OSDI) questionnaires, non-invasive tear break-up time (NIBUT), Schirmer I, and keratoepitheliopathy scores was administered before applying UCS drop and at week 2 and 4 of eye drop use. Results: From June 2020 to December 2020, five eyes of five patients were evaluated in this study. Patients were aged from 22 to 71 years old with history of SJS over periods from 1 to 35 years. Three patients underwent ocular surgeries prior to the study. After four weeks of treatment, symptoms score, Schirmer I, and keratoepitheliopathy scores improved significantly, while NIBUT scores improved insignificantly. No side effects were noted during treatment. Conclusion: Administration of UCS eye drop was effective in improving symptoms and signs of dry eye in chronic SJS patients.

[1]  C. Sotozono,et al.  Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage. , 2018, Investigative ophthalmology & visual science.

[2]  E. Campos,et al.  Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[3]  M. Moshirfar,et al.  Amniotic membrane extract and eye drops: a review of literature and clinical application , 2018, Clinical ophthalmology.

[4]  J. Wolffsohn,et al.  TFOS DEWS II Diagnostic Methodology report. , 2017, The ocular surface.

[5]  J. Chodosh,et al.  Ocular manifestations of Stevens–Johnson syndrome and their management , 2016, Current opinion in ophthalmology.

[6]  C. Sotozono,et al.  Stevens-Johnson syndrome: The role of an ophthalmologist. , 2016, Survey of ophthalmology.

[7]  Anthony J. Johnson,et al.  Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. , 2016, The ocular surface.

[8]  D. Sullivan,et al.  Growth Hormone Influence on the Morphology and Size of the Mouse Meibomian Gland , 2016, Journal of ophthalmology.

[9]  E. Sutedja,et al.  Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013 , 2016, Asia Pacific allergy.

[10]  K. Yoon.  Use of Umbilical Cord Serum in Ophthalmology , 2014, Chonnam medical journal.

[11]  E. Campos,et al.  Efficacy of Standardized and Quality-Controlled Cord Blood Serum Eye Drop Therapy in the Healing of Severe Corneal Epithelial Damage in Dry Eye , 2013, Cornea.

[12]  S. Kinoshita,et al.  Ocular surface inflammation is regulated by innate immunity , 2012, Progress in Retinal and Eye Research.

[13]  N. Sharma,et al.  Bilateral Microbial Keratitis in Highly Active Antiretroviral Therapy-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Case Series , 2011, Ocular immunology and inflammation.

[14]  P. Lertrit,et al.  Stability of Epitheliotrophic Factors in Autologous Serum Eye Drops from Chronic Stevens-Johnson Syndrome Dry Eye Compared to Non-autoimmune Dry Eye , 2011, Current eye research.

[15]  Won Choi,et al.  Application of Umbilical Cord Serum Eyedrops for Recurrent Corneal Erosions , 2011, Cornea.

[16]  G. Purdue,et al.  Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. , 2010, American journal of ophthalmology.

[17]  N. Koizumi,et al.  Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. , 2009, Ophthalmology.

[18]  G. Soubrane,et al.  Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2009, Archives of dermatology.

[19]  Yuan-Tsong Chen,et al.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.

[20]  K. Yoon,et al.  Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. , 2007, Ophthalmology.

[21]  D. Dhaliwal,et al.  Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. , 2007, Journal of cataract and refractive surgery.

[22]  K. Yoon,et al.  Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. , 2007, American journal of ophthalmology.

[23]  K. Tsubota,et al.  New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. , 2007, Ophthalmology.

[24]  B. Thong,et al.  Ocular manifestations and complications of Stevens–Johnson syndrome and toxic epidermal necrolysis: an Asian series * , 2007, Allergy.

[25]  M. Leyland,et al.  Early pathological features of the cornea in toxic epidermal necrolysis , 2007, British Journal of Ophthalmology.

[26]  J. Dart,et al.  The natural history of Stevens–Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy , 2007, British Journal of Ophthalmology.

[27]  M. Helvaci,et al.  Ocular Surface Disease Index for the Diagnosis of Dry Eye Syndrome , 2007, Ocular immunology and inflammation.

[28]  K. Yoon,et al.  Application of Umbilical Cord Serum Eyedrops for the Treatment of Dry Eye Syndrome , 2006, Cornea.

[29]  K. Yoon,et al.  Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. , 2005, Korean journal of ophthalmology : KJO.

[30]  Wei Li,et al.  Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. , 2005, Ophthalmology.

[31]  T. Nishida,et al.  A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability. , 2003, Archives of ophthalmology.

[32]  R. Pandey,et al.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects , 2003, The British journal of ophthalmology.

[33]  C. Murphy,et al.  Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.

[34]  S. Pflugfelder,et al.  Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. , 1996, Current eye research.

[35]  K. Tsubota,et al.  Serum Application for the Treatment of Ocular Surface Disorders , 2000, International ophthalmology clinics.